NYSE:COV - Covidien Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.0350
Today's Range$0.0350 - $0.0350
52-Week Range$65.97 - $108.57
VolumeN/A
Average Volume3.88 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Receive COV News and Ratings via Email

Sign-up to receive the latest news and ratings for COV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
CUSIPG2554F11
WebN/A
Phone+353-1-4381700

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Covidien (NYSE:COV) Frequently Asked Questions

What is Covidien's stock symbol?

Covidien trades on the New York Stock Exchange (NYSE) under the ticker symbol "COV."

How were Covidien's earnings last quarter?

Covidien Ltd (NYSE:COV) posted its earnings results on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.02 by $0.13. The healthcare company had revenue of $2.73 billion for the quarter, compared to the consensus estimate of $2.69 billion. Covidien's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business earned $0.91 earnings per share. View Covidien's Earnings History.

Has Covidien been receiving favorable news coverage?

Press coverage about COV stock has been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Covidien earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave news headlines about the healthcare company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.

Who are Covidien's key executives?

Covidien's management team includes the folowing people:
  • Gary L. Ellis, President, Chief Executive Officer (Age 61)
  • Charles J. Dockendorff, Chief Financial Officer, Executive Vice President (Age 63)
  • Bryan C. Hanson, Group President, Covidien (Age 50)
  • John H. Masterson, Senior Vice President, General Counsel (Age 54)
  • Michael P. Dunford, Senior Vice President - Human Resources (Age 54)
  • James C. Clemmer, Senior Vice President and President - Medical Supplies Business (Age 53)
  • Amy A. McBride-Wendell, Senior Vice President - Strategy and Business Development (Age 53)
  • Jacqueline F. Strayer, Senior Vice President-Corporate Communications (Age 58)
  • Michael E. Tarnoff, Senior Vice President,Chief Medical Officer (Age 46)
  • Peter L. Wehrly, Senior Vice President, Group President - Developed Markets (Age 57)

How do I buy shares of Covidien?

Shares of COV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Covidien?

Covidien's mailing address is 20 On Hatch Lower Hatch Street, Dublin 2, DUBLIN,, Ireland. The healthcare company can be reached via phone at +353-1-4381700.


MarketBeat Community Rating for Covidien (NYSE COV)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  361 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  567
MarketBeat's community ratings are surveys of what our community members think about Covidien and other stocks. Vote "Outperform" if you believe COV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel